Adicet Bio (ACET) director receives 4,200 stock options at $8.10 strike
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Adicet Bio, Inc. director Andrew Sinclair received a grant of stock options as part of his board compensation. He was awarded 4,200 stock options to purchase Adicet Bio common stock at an exercise price of $8.10 per share. These options expire on June 20, 2036. They vest in full on the earlier of the first anniversary of the grant date or the next annual meeting of stockholders after the grant date, subject to his continued service on the board. Following this award, Sinclair holds 4,200 derivative securities linked to Adicet Bio common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Sinclair Andrew
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 4,200 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 4,200 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Options granted: 4,200 options
Exercise price: $8.10 per share
Expiration date: June 20, 2036
+3 more
6 metrics
Options granted
4,200 options
Director stock option grant
Exercise price
$8.10 per share
Stock option exercise price
Expiration date
June 20, 2036
Option term end
Shares underlying options
4,200 shares
Underlying common stock
Vesting condition
Earlier of 1-year anniversary or next annual meeting
Subject to continued board service
Total derivative holdings after grant
4,200 options
Post-transaction position
Key Terms
Stock Option (Right to Buy), exercise price, expiration date, underlying security, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
exercise price financial
"conversion_or_exercise_price: 8.1000"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-06-20T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
underlying security financial
"underlying_security_title: Common Stock"
vesting financial
"These shares shall vest in full on the earlier to occur of (i) the first anniversary of the grant date or (ii) the date of the next annual meeting"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
What insider transaction did Adicet Bio (ACET) report for Andrew Sinclair?
Adicet Bio reported that director Andrew Sinclair received a grant of 4,200 stock options to buy common shares at an exercise price of $8.10. This is a compensation-related award, not an open-market purchase or sale of existing shares.
How many Adicet Bio (ACET) stock options were granted to Andrew Sinclair?
Andrew Sinclair was granted 4,200 stock options linked to Adicet Bio common stock. These options give him the right to buy up to 4,200 shares at a fixed $8.10 exercise price if and when the options vest and are exercised.
What is the exercise price and expiration date of Andrew Sinclair’s Adicet Bio options?
The granted options have an exercise price of $8.10 per share and an expiration date of June 20, 2036. This means Sinclair can choose to exercise the options at $8.10 any time after vesting and before they expire in 2036.
When do Andrew Sinclair’s Adicet Bio (ACET) stock options vest?
The options vest in full on the earlier of the first anniversary of the grant date or the next annual meeting of stockholders after the grant. Vesting is conditioned on Sinclair’s continued service on Adicet Bio’s board of directors through that vesting date.
How many Adicet Bio derivative securities does Andrew Sinclair hold after this grant?
After this transaction, Andrew Sinclair holds 4,200 derivative securities in the form of stock options. These options represent the right to acquire up to 4,200 Adicet Bio common shares at the fixed $8.10 exercise price, subject to vesting and future exercise.